About Iantrek
Iantrek is a company based in White Plains (United States) founded in 2019 by Sean Ianchulev. Iantrek has raised $97.78 million across 4 funding rounds from investors including Visionary Ventures, Sectoral Asset Management and USVP. The company has 2 employees as of December 31, 2021. Iantrek offers products and services including CycloPen, AlloFlo, and C-Rex. Iantrek operates in a competitive market with competitors including Sight Sciences, Alcon, Keranova, Zhitong Technology and Migos Medical, among others.
- Headquarter White Plains, United States
- Employees 2 as on 31 Dec, 2021
- Founders Sean Ianchulev
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Iantrek, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$97.78 M (USD)
in 4 rounds
-
Latest Funding Round
$30 M (USD), Series C
Apr 29, 2026
-
Investors
Visionary Ventures
& 5 more
-
Employee Count
2
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Iantrek
Iantrek offers a comprehensive portfolio of products and services, including CycloPen, AlloFlo, and C-Rex.
System for controlled creation of cyclodialysis in glaucoma surgery.
Enhances outflow in eyes through precision scleral reinforcement.
Device for circumferential, excisional goniotomy procedures.
People of Iantrek
Unlock access to complete
Unlock access to complete
Funding Insights of Iantrek
Iantrek has successfully raised a total of $97.78M across 4 strategic funding rounds. The most recent funding activity was a Series C round of $30 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Iantrek
Iantrek has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Visionary Ventures, Sectoral Asset Management and USVP.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A venture capital fund focused on life sciences investments.
|
Locked | Locked | Locked | |
|
Sectoral Asset Management is focused on global healthcare investment.
|
Locked | Locked | Locked | |
|
VC firm that focuses on early stage investments in the US
|
Locked | Locked | Locked |
Investor details for Iantrek
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Iantrek
Investment portfolio details for Iantrek
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Iantrek
Detailed financials for Iantrek
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Iantrek Comparisons
Peer comparison for Iantrek
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Iantrek
Iantrek operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sight Sciences, Alcon, Keranova, Zhitong Technology and Migos Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Surgical systems for ophthalmological disease treatment are developed.
|
|
| Locked | Locked | Locked |
Developer of a wide range of eye care products
|
|
| Locked | Locked | Locked |
Surgical equipment for anterior chamber ophthalmic surgery is developed.
|
|
| Locked | Locked | Locked |
Developer of surgical devices for ophthalmic indications
|
|
| Locked | Locked | Locked |
Minimally invasive ophthalmology devices for glaucoma are developed.
|
Detailed competitors of Iantrek
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Iantrek
Complete news archive for Iantrek
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Iantrek
Iantrek was founded in 2019 and raised its 1st funding round 3 years after it was founded.
Iantrek is headquartered in White Plains, United States. It is registered at White Plains, New York, United States.
Sean Ianchulev is the current CEO of Iantrek. They have also founded this company.
Iantrek is a funded company, having raised a total of $97.78M across 4 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Iantrek is 2.
Iantrek was founded in 2019 in White Plains, United States, within the medical devices sector focused on ophthalmology. A minimally invasive technology for eye surgery is developed, featuring an implantable biologic stent. This stent is surgically placed to boost aqueous outflow and decrease intraocular pressure, addressing conditions like glaucoma. Operations center on innovation in biologic implants for improved surgical outcomes in eye care.
Iantrek's top competitors include Alcon, Sight Sciences and Keranova.
Iantrek offers CycloPen, AlloFlo, and C-Rex.
Iantrek has 6 investors. Key investors include Visionary Ventures, Sectoral Asset Management, USVP, JSD I Radius Special Situations, and Civilization Ventures.